Log in to save to my catalogue

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Scler...

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Scler...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e14b1bd9c2041c4a6c21f56c3686f6d

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis

About this item

Full title

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2025-02, Vol.18 (2), p.259

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are severe complications of patients with systemic sclerosis (SSc). Currently, there are a few tests for early identification of these conditions, although they are invasive and time-consuming. Extracellular vesicles (EVs) offer a promising possibility for gathering informati...

Alternative Titles

Full title

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9e14b1bd9c2041c4a6c21f56c3686f6d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e14b1bd9c2041c4a6c21f56c3686f6d

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph18020259

How to access this item